The destruction of islet cells in mice upon administering streptozotocin led to hyperglycemia, intravascular oxidant production, DNA strand breakage, PARP activation, and a selective loss of endothelium-dependent vasodilation. This evidence concerns the gene PARP1 and Hyperglycemia.